Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Teresa DeLuca Insider Profile
11 Followers
Teresa DeLuca, Director at Surgery Partners, holds 52.16K shares in Surgery Partners (Ticker: SGRY), holds 625.00 shares in 180 Life Sciences (Ticker: ATNF).
Profitable Transactions
6 out of 9 Profitable Transactions
Average Return
-0.90%
Average return per transaction
Time Frame
Compare to
Insider Holdings
Insider Roles
Roles that Teresa DeLuca holds in companies
Most Profitable Insider Trade
The most profitable trade made by Teresa DeLuca
Teresa DeLuca's Trading History
Surgery Partners
Apr 05, 2024
Director
Uninformative Buy
159.97K
$1.34M
180 Life Sciences
Dec 13, 2021
Director
Informative Buy
49.80K
$1.17K
List of latest transactions for each holding click on a transaction to see Teresa DeLuca's performance on stock
You May Also Like
Teresa DeLuca insider profile FAQ
What is the percentage of profitable transactions made by Teresa DeLuca?
The percentage of profitable transactions made by Teresa DeLuca is 67%.
What is the average return per transaction made by Teresa DeLuca?
The average return per transaction made by Teresa DeLuca is -0.90%.
What stocks does Teresa DeLuca hold?
Teresa DeLuca holds: SGRY, ATNF stocks.
What was Teresa DeLuca’s latest transaction?
Teresa DeLuca latest transaction was an Uninformative Buy of $159.97K.
What was Teresa DeLuca's most profitable transaction?
Teresa DeLuca’s most profitable transaction was an Informative Buy of SGRY stock on September 10, 2019. The return on the trade was 163.50%.
What is Teresa DeLuca's role in Surgery Partners?
Teresa DeLuca's role in Surgery Partners is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.